APA (7th ed.) Citation

Guymer, R. H., Silva, R., Ghadessi, M., Leal, S., Gashaw, I., Damask, A., . . . Rittenhouse, K. D. (2024). ANO2 Genetic Variants and Anti-VEGF Treatment Response in Neovascular AMD: A Pharmacogenetic Substudy of VIEW 1 and VIEW 2. Investigative ophthalmology & visual science, 65(8), 17. https://doi.org/10.1167/iovs.65.8.17

Chicago Style (17th ed.) Citation

Guymer, Robyn H., Rufino Silva, Mercedeh Ghadessi, Sergio Leal, Isabella Gashaw, Amy Damask, Charles Paulding, and Kay D. Rittenhouse. "ANO2 Genetic Variants and Anti-VEGF Treatment Response in Neovascular AMD: A Pharmacogenetic Substudy of VIEW 1 and VIEW 2." Investigative Ophthalmology & Visual Science 65, no. 8 (2024): 17. https://doi.org/10.1167/iovs.65.8.17.

MLA (9th ed.) Citation

Guymer, Robyn H., et al. "ANO2 Genetic Variants and Anti-VEGF Treatment Response in Neovascular AMD: A Pharmacogenetic Substudy of VIEW 1 and VIEW 2." Investigative Ophthalmology & Visual Science, vol. 65, no. 8, 2024, p. 17, https://doi.org/10.1167/iovs.65.8.17.